Cann Group Ltd. · ASX:CAN
Cann — Corporate Update (October 2021)
19 slides from Cann's corporate update, Oct 1, 2021
Slide 1: Shareholder update ASX announcement
ASX ANNOUNCEMENT 1 October 2021 Shareholder update For personal use only 1 October 2021 – Melbourne based Cann Group (Company) is pleased to invite shareholders, investors and interested parties to today’s investor update webinar and Q&A with CEO Peter Crock and COO Shane Duncan. The webinar will be
Slide 2: Shareholder Update October 2021
For personal use only Shareholder Update October 2021 * *Overseas product - not available in Australia
Slide 3: Disclaimer: Important notice
Disclaimer: Important notice IMPORTANT: You must read the following before continuing. For personal use only This notice and disclaimer applies to this investor presentation (Presentation) and you are therefore advised to read this carefully before reading or making any other use of this Presentatio
Slide 4: Disclaimer: Important notice
Disclaimer: Important notice Not investment advice For personal use only Each recipient of this Presentation should make its own enquiries and investigations regarding all information in this Presentation including but not limited to the assumptions, uncertainties and contingencies which may affect
Slide 5: Disclaimer: Important notice
Disclaimer: Important notice Acceptance, Withdrawal and Cooling-off For personal use only By attending an investor presentation or briefing, or accepting, assessing or reviewing this Presentation you acknowledge and agree to the terms set out in this “Disclaimer: Important Notice” section of this Pr
Slide 6: Mildura: On schedule; initial commissioning stages underway
Mildura: On schedule; initial commissioning stages underway For personal use only February 2021 June 2021 August 2021 November 2021* Building works recommence and Laboratory Pilot scale extraction equipment Planned TGA analytical lab refit commences commissioning begins installation inspection of Ge
Slide 7: Mildura – laboratory now operational
Mildura – laboratory now operational For personal use only 6
Slide 8: Mildura – manufacturing & extraction suites completed
Mildura – manufacturing & extraction suites completed For personal use only 7
Slide 9: Mildura – cultivation facility progresses
Mildura – cultivation facility progresses For personal use only 8
Slide 10: Commercial update – Southern project
Commercial update – Southern project For personal use only Construction complete TGA inspection scheduled Provides ability to produce cGMP packed flower at substantial cost saving over third-party Cann’s recently completed Southern Facility upgrade ready for GMP inspection supply 9
Slide 11: Commercial update – S3 project
Commercial update – S3 project For personal use only Clinical research organisation appointed Trial design Indication Clinical trial preparation underway CBD only product based on unique formulation and delivery platform 10
Slide 12: Summary
Summary For personal use only 1 Executing on a strategy to build world-class capability; a globally competitive cost position; and a pipeline of proprietary products that access significant and growing markets around the world 2 Investing in an integrated supply chain Expanding market access v
Slide 13: Appendix
For personal use only 12 Appendix
Slide 14: Key risks
Key risks Topic Summary For personal use only Cann is in the process of building its third facility (being at an undisclosed location in the vicinity of Mildura) (Mildura Facility), by way of a staged construction and commissioning process, comprising three stages. Once the first stage (1A) is commi
Slide 15: Key risks
Key risks Topic Summary For personal use only Cann’s business operates in a highly regulated industry, which brings a number of industry risks common amongst those businesses that operate in this space. These include those described below, and each risk (if not mitigated successfully or appropriatel
Slide 16: Key risks
Key risks Topic Summary For personal use only Cann’s ability to continue the production of cannabis and/or the manufacture of products derived from cannabis at the same pace as it is currently producing or at all, and its ability to continue to increase both its production capacity and actual produc
Slide 17: Key risks
Key risks Topic Summary For personal use only Part of the funds that Cann is seeking from investors are to be used by Cann to become more vertically integrated, including by installing and commissioning extraction and Gelpell manufacturing at the Mildura Facility, and Vertical integration building c
Slide 18: Key risks – General risks
Key risks For personal use only General risks Topic Summary There are inherent risks associated with investment in any listed company. The New Shares under the Offer do not guarantee payment of dividends, return on capital or maintenance of capital or value. No Nature of investment assurances can be
Slide 19: Contacts
For personal use only CONTACTS: Clive Fanning Head of Investor Relations Cann Group Limited +61 (0) 3 9095 7088 contact@canngrouplimited.com Peter Crock CEO Cann Group Limited +61 (0) 3 9095 7088 contact@canngrouplimited.com 18